Filter

Showing 1–12 of 38 results

2020 FDA Approvals Adalimumab
+
 Quick View

anti-human

Adalimumab Biosimilar – Research Grade [ICH4001]

$704.00 – $4,080.00
2020 FDA Approvals Ado-trastuzumab-emtansine
+
 Quick View

anti-human

Ado-trastuzumab emtansine Biosimilar – Research Grade [ICH4014]

$1,122.00 – $2,550.00
2020 FDA Approvals Aflibercept
+
 Quick View

anti-human

Aflibercept Biosimilar – Research Grade [ICH4015]

$600.00 – $2,550.00
2020 FDA Approvals for Alemtuzumab
+
 Quick View

anti-human

Alemtuzumab Biosimilar – Research Grade [ICH4002]

$704.00 – $4,080.00
2020 FDA Approvals Alirocumab
+
 Quick View

anti-human

Alirocumab Biosimilar – Research Grade [ICH4016]

$704.00 – $4,080.00
2020 FDA Approvals Atezolizumab
+
 Quick View

anti-human

Atezolizumab Biosimilar – Research Grade [ICH4018]

$704.00 – $4,080.00
2020 FDA Approvals Avelumab
+
 Quick View

anti-human

Avelumab Biosimilar – Research Grade [ICH4017]

$704.00 – $4,080.00
2020 FDA Approvals Bevacizumab
+
 Quick View

anti-human

Bevacizumab Biosimilar – Research Grade [ICH4003]

$704.00 – $4,080.00
+
 Quick View

anti-human

Camrelizumab Biosimilar – Research Grade [ICH5003]

$704.00 – $7,700.00
2020 FDA Approvals Cetuximab
+
 Quick View

anti-human

Cetuximab Biosimilar – Research Grade [ICH4004]

$704.00 – $4,080.00
2020 FDA Approvals Denosumab
+
 Quick View

anti-human

Denosumab Biosimilar – Research Grade [ICH4019]

$704.00 – $4,080.00
+
 Quick View

anti-human

Durvalumab Biosimilar – Research Grade [ICH5005]

$704.00 – $7,700.00
View Cart Checkout Continue Shopping